WED-230-YI A novel MELD-copeptin score accurately predicts ACLF and liver- related death in patients with decompensated cirrhosis
Marlene HINTERSTEININGER(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Joan Clària(European Foundation for the Study of Chronic Liver Failure), Michael Schwarz(Medical University of Vienna), Annarein Kerbert(Leiden University Medical Center), Nina Dominik(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences), Jonel Trebicka(Klinik für Schlafmedizin), Lukas Hartl(Medical University of Vienna), Minneke J. Coenraad(Leiden University Medical Center), Mattias Mandorfer(Medical University of Vienna), Benedikt Hofer(Austrian Academy of Sciences), Rodrig Marculescu(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Michael Trauner(Medical University of Vienna), Lorenz Balcar(Medical University of Vienna), David JM Bauer(Brigham and Women's Hospital), Georg Kramer(Medical University of Vienna), Thierry Thévenot(Inserm), Richard Moreau(Mizoram University)
Cited by 0
Related Papers
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k